NO20010532L - Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid - Google Patents

Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid

Info

Publication number
NO20010532L
NO20010532L NO20010532A NO20010532A NO20010532L NO 20010532 L NO20010532 L NO 20010532L NO 20010532 A NO20010532 A NO 20010532A NO 20010532 A NO20010532 A NO 20010532A NO 20010532 L NO20010532 L NO 20010532L
Authority
NO
Norway
Prior art keywords
carotenoid
carnitine
antioxidant
composition
dietary supplement
Prior art date
Application number
NO20010532A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010532D0 (no
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20010532D0 publication Critical patent/NO20010532D0/no
Publication of NO20010532L publication Critical patent/NO20010532L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20010532A 1998-08-03 2001-01-31 Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid NO20010532L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998RM000516A IT1302125B1 (it) 1998-08-03 1998-08-03 Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
PCT/IT1999/000251 WO2000007581A2 (fr) 1998-08-03 1999-07-29 Composition antioxydante et antiproliferante comprenant une carnitine et un carotenoide

Publications (2)

Publication Number Publication Date
NO20010532D0 NO20010532D0 (no) 2001-01-31
NO20010532L true NO20010532L (no) 2001-03-20

Family

ID=11406082

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010532A NO20010532L (no) 1998-08-03 2001-01-31 Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid

Country Status (21)

Country Link
EP (1) EP1102584A2 (fr)
JP (1) JP2002522382A (fr)
KR (1) KR20010072146A (fr)
CN (1) CN1311674A (fr)
AR (1) AR021172A1 (fr)
AU (1) AU5064199A (fr)
BR (1) BR9912703A (fr)
CA (1) CA2338035A1 (fr)
EE (1) EE200100052A (fr)
HK (1) HK1039062A1 (fr)
HU (1) HUP0102807A2 (fr)
IL (1) IL140797A0 (fr)
IS (1) IS5816A (fr)
IT (1) IT1302125B1 (fr)
MA (1) MA26666A1 (fr)
NO (1) NO20010532L (fr)
PL (1) PL346161A1 (fr)
SK (1) SK1252001A3 (fr)
TN (1) TNSN99152A1 (fr)
TR (1) TR200100333T2 (fr)
WO (1) WO2000007581A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL212211B1 (pl) 2000-06-02 2012-08-31 Regents Board Of Kompozycja do wytwarzania scyntygraficznego środka obrazującego, kompozycja do obrazowania scyntograficznego, sposób syntezy znakowanego radionuklidem koniugatu etylenodicysteiny z ligandem naprowadzającym do obrazowania, zastosowanie kompozycji zawierającej znakowany radionklidem konigat etylenodiscysteiny z ligandem naprowadzającym do wytwarzania środków farmaceutycznych do obrazowania nowotworu albo miejsca infekcji oraz zestaw do wytwarzania preparatów radiofarmaceutycznych
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
KR100523562B1 (ko) 2001-10-29 2005-10-25 한국과학기술연구원 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물
JP4527938B2 (ja) * 2002-07-23 2010-08-18 オルビス株式会社 抗酸化用の経口投与組成物
JP4334189B2 (ja) * 2002-07-30 2009-09-30 カゴメ株式会社 Ａｇｅ生成阻害剤
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
DK1614684T3 (da) 2003-04-14 2009-04-14 Nippon Soda Co Diaminderivat, produktionsproces og antioxidantlægemiddel
US9050378B2 (en) 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
PT1711070E (pt) * 2004-01-28 2016-02-15 Nestec Sa Composição nutricional para melhorar o estado da pele e prevenir doenças de pele
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
RU2619342C1 (ru) * 2016-02-24 2017-05-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Препарат для профилактики и лечения свободнорадикальной патологии у животных
CN113491687A (zh) * 2020-04-02 2021-10-12 常州高新技术产业开发区三维工业技术研究所有限公司 一种解毒药物组合物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
EP0400547A1 (fr) * 1989-06-02 1990-12-05 Abbott Laboratories Produit de nutrition parentéral
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito

Also Published As

Publication number Publication date
AR021172A1 (es) 2002-07-03
CA2338035A1 (fr) 2000-02-17
WO2000007581A2 (fr) 2000-02-17
IT1302125B1 (it) 2000-07-31
EP1102584A2 (fr) 2001-05-30
SK1252001A3 (en) 2001-08-06
WO2000007581A3 (fr) 2000-05-11
IS5816A (is) 2001-01-16
ITRM980516A0 (it) 1998-08-03
JP2002522382A (ja) 2002-07-23
BR9912703A (pt) 2001-05-02
EE200100052A (et) 2002-06-17
HK1039062A1 (zh) 2002-04-12
IL140797A0 (en) 2002-02-10
ITRM980516A1 (it) 2000-02-03
CN1311674A (zh) 2001-09-05
KR20010072146A (ko) 2001-07-31
PL346161A1 (en) 2002-01-28
MA26666A1 (fr) 2004-12-20
TNSN99152A1 (fr) 2005-11-10
HUP0102807A2 (hu) 2002-03-28
TR200100333T2 (tr) 2001-07-23
NO20010532D0 (no) 2001-01-31
AU5064199A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
NO20010532L (no) Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid
WO2000011968A8 (fr) Composition antioxydante renfermant de l'acetyl-l-carnitine et de l'acide alpha-lipoique
WO1999066913A3 (fr) Composition utilisee dans la prevention et/ou le traitement de l'osteoporose et modifications induites par le syndrome de la menopause
DK0659402T3 (da) Formuleringer indeholdende carotenoider og procarotenoider kombineret med polyphenoler til forebyggelse af beskadigelser som følge af abnorm produktion af frie radikaler
DE69629273D1 (de) Zusammensetzungen enthaltend Propionyl-L-Carnitine und Hydroxyzitronensäure oder Pantothensäure
ES2137628T3 (es) Derivados de estilbeno y composiciones farmaceuticas que los contienen.
EP1072254A4 (fr) Compositions alimentaires, compositions orales et compositions medicinales servant a prevenir ou traiter la parodontose et procede de prevention ou de traitement de la parodontose
DK0465343T3 (da) Farmaceutisk eller kosmetisk præparat indeholdende en kombination af et retinoid og en sterol
BR9916197A (pt) Método para o tratamento de isquemia cerebral e uso de eritropoietina ou derivados de eritropoietina para o tratamento de isquemia cerebral
NO20006430L (no) Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner
BRPI0417104A (pt) composto, processo para a preparação de um composto, composição fungicida e método para o combate preventivo ou curativo de fungos fitopatogênicos de plantações
NO20011693L (no) Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelser
DK0773022T3 (da) Farmaceutisk sammensætning til behandling af rhinitis indeholdende sympathomimetika og pantothenol og/eller pantothensyre
DK0951909T4 (da) Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
ECSP034518A (es) Nuevos retinoides para el tratamiento de enfisema
NO20021640L (no) Sammensetning til forebygging og/eller behandling av kretslöpsykdommer som omfatter derivater av L-karnitin ogekstrakter av Gingo biloba
BRPI0405445A (pt) Métodos para tratamento de condições da pele
BR0009859A (pt) Composições fungicidas para proteção das frutas, processo de tratamento das frutas e frutas tratadas
WO2000000183A3 (fr) Composition antioxydante, cytostatique et a energie durable, ameliorant l'utilisation metabolique du glucose
ES2134284T3 (es) Pirido-pirimidindionas, procedimiento para su preparacion y su empleo como medicamentos.
CA2350220A1 (fr) Composition antioxydante renfermant de la l-carnitine de propionyle et un flavonoide pour lutter contre la thrombose et l'atherosclerose
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
NO20022288D0 (no) Sammensetning til forebygging og/eller behandling av forstyrrelser forårsaket av abnorm lipid metabolisme, sominnbefatter propionyl L-karnitin og kitosan
NO20011430D0 (no) Anvendelse av organofosforforbindelser for fremstilling av medikamenter for terapeutisk og profylaktisk behandling av infeksjoner, eller som et fungicid, baktericid eller herbicid for planter
AU2002333535A1 (en) Treatment of excessive radiation (e.g. sunburn) exposure

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application